Unlock stock picks and a broker-level newsfeed that powers Wall Street.
IOB - Delayed Quote SEK

BioGaia AB (publ) (0GTN.IL)

Compare
102.00
-6.50
(-5.99%)
At close: April 4 at 4:24:02 PM GMT+1
Loading Chart for 0GTN.IL
  • Previous Close 108.50
  • Open 103.90
  • Bid --
  • Ask --
  • Day's Range 101.90 - 104.90
  • 52 Week Range 95.90 - 136.50
  • Volume 1,306
  • Avg. Volume 4,320
  • Market Cap (intraday) 10.576B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 24.76
  • EPS (TTM) 4.12
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield 1.45 (1.48%)
  • Ex-Dividend Date May 9, 2023
  • 1y Target Est --

BioGaia AB (publ), a healthcare company, develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; Helicobacter pylori–the gastric ulcer bacterium; low bone density; and diverticulitis, as well as baby and child gut, adult gut, immune, pregnancy, oral, and bone health. It offers its products under the BioGaia brand name. The company sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

www.biogaia.com

212

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0GTN.IL

View More

Performance Overview: 0GTN.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

0GTN.IL
8.85%
OMX Stockholm 30 Index (^OMX)
7.89%

1-Year Return

0GTN.IL
8.51%
OMX Stockholm 30 Index (^OMX)
9.30%

3-Year Return

0GTN.IL
4.68%
OMX Stockholm 30 Index (^OMX)
7.06%

5-Year Return

0GTN.IL
31.64%
OMX Stockholm 30 Index (^OMX)
62.84%

Compare To: 0GTN.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0GTN.IL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    10.27B

  • Enterprise Value

    9.04B

  • Trailing P/E

    29.31

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.25

  • Price/Book (mrq)

    5.99

  • Enterprise Value/Revenue

    6.36

  • Enterprise Value/EBITDA

    16.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    34.36%

  • Return on Assets (ttm)

    12.21%

  • Return on Equity (ttm)

    22.82%

  • Revenue (ttm)

    1.27B

  • Net Income Avi to Common (ttm)

    437.42M

  • Diluted EPS (ttm)

    4.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.45B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    247.83M

Research Analysis: 0GTN.IL

View More

Company Insights: 0GTN.IL

Research Reports: 0GTN.IL

View More

People Also Watch